STEGLATRO is a prescription pill used in adults with type 2 diabetes to improve blood sugar (glucose) control along with diet and exercise. STEGLATRO is not for people with type 1 diabetes. It may increase the risk of diabetic ketoacidosis in these people.



Clinical Results With STEGLATRO

STEGLATRO was proven to lower A1C levels in some patients

STEGLATRO was studied for 26 weeks in adults with type 2 diabetes whose A1C was not controlled with diet and exercise alone. In this clinical study, STEGLATRO helped people to:

Learn About STEGLATRO® (ertugliflozin) and A1C

Significantly lower A1C levels

  • STEGLATRO 5 mg lowered A1C an average of 0.7%, from 8.2% at start
  • STEGLATRO 15 mg lowered A1C an average of 0.8%, from 8.4% at start
  • Placebo lowered A1C an average of 0.2%, from 8.1% at start
Talk to Your Doctor About What A1C Goal is Right for You

May help reach A1C goals

In the same study, almost twice as many people who took the starting dose of STEGLATRO (5 mg) reached an A1C of less than 7% as compared to placebo.

Percent of people in the study who reached an A1C goal of less than 7%:

  • ~30% who took STEGLATRO 5 mg
  • ~39% who took STEGLATRO 15 mg
  • ~17% who took placebo

For many adults with diabetes, the American Diabetes Association recommends an A1C goal of less than 7%. Be sure to talk to your doctor about what A1C goal is right for you.

Learn About STEGLATRO® (ertugliflozin) and Your Weight

May help you lose weight

Although it's not a weight loss medication, STEGLATRO may help you lose some weight.

The people participating in the same study lost on average 5 pounds more than those taking placebo.

Average weight loss for people in the same study:

  • STEGLATRO 5 mg: people lost an average of 7 pounds from 207 pounds at start
  • STEGLATRO 15 mg: people lost an average of 7 pounds from 200 pounds at start
  • Placebo: people lost an average of 2 pounds from 208 pounds at start
STEGLATRO is 1 pill, taken 1 time a day in the morning, and is available in 5 or 15 mg tablets. The starting dose of STEGLATRO is 5 mg.

STEGLATRO has been tested in 7 clinical studies that looked at its benefits and safety. The studies included more than 4,800 adults with type 2 diabetes.

Is it time to add STEGLATRO?

Ask your doctor if STEGLATRO, along with diet and exercise, could help lower your A1C level.

Savings on STEGLATRO® (ertugliflozin) for Eligible, Privately Insured Patients

Not an actual coupon.

Pay as little as $0 per prescription*

Eligible, privately insured patients may pay as little as $0 per prescription on each of up to 12 qualifying prescriptions. Maximum savings is $583 per prescription.


*Not all patients are eligible. Certain restrictions apply. Please see Terms and Conditions.



Copyright © 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.

This site is intended only for residents of the United States, its territories, and Puerto Rico. US-STE-01456 02/22

Do not take STEGLATRO if you:

  • are allergic to ertugliflozin or any of the ingredients in STEGLATRO. Symptoms of a serious allergic reaction to STEGLATRO may include skin rash, raised red patches on your skin (hives), and swelling of the face, lips, tongue, and throat that may cause difficulty in breathing or swallowing. If you have any symptoms of a serious allergic reaction, stop taking STEGLATRO and call your doctor right away.
  • are on dialysis.